1,086 material Form 8-K filings that 883 companies we cover made with the SEC in July 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Dorian LPG reported results for the quarter ended June 30, 2025, with revenues down 26.4% to $84.2 million and net income down to $10.1 million, or $0.24 per diluted share, from $51.3 million, or $1.25, a year earlier. The company also declared an irregular dividend of $0.60 per share, about $25.6 million in total, payable on or about August 27, 2025 to holders of record on August 12, 2025, though the company states that future dividends are at the discretion of its board.
Revenues were $84.2 million, down $30.1 million, or 26.4%, from $114.3 million, mainly due to lower average TCE rates and fewer available days.
Net income was $10.1 million, or $0.24 per diluted share, versus $51.3 million, or $1.25 per share, in the same quarter of 2024.
TCE rate per available day was $39,726, down 20.9% from $50,243; general and administrative expenses rose 62.2% to $16.9 million.
Irregular dividend of $0.60 per share (about $25.6 million), payable on or about August 27, 2025 to shareholders of record as of August 12, 2025.
MasTec reported second quarter 2025 revenue of $3.5 billion, up 20% from a year earlier, and GAAP diluted earnings per share of $1.09, up from $0.43. The company raised its full year 2025 diluted EPS guidance midpoint to $4.71 and adjusted diluted EPS guidance midpoint to $6.33, which indicates higher expected earnings for shareholders.
Q2 2025 revenue was $3,545 million versus $2,961 million in Q2 2024, a 19.7% increase; Pipeline Infrastructure revenue fell 5.7%.
Q2 2025 adjusted diluted EPS was $1.49 versus $1.00 a year earlier; GAAP net income was $90.1 million.
Full year 2025 guidance: revenue of $13.9 billion to $14.0 billion and GAAP diluted EPS of $4.61 to $4.82.
Six-month free cash flow was $(0.4) million, compared with $346.4 million in the prior-year period.
Quaker Houghton reported second-quarter 2025 net sales of $483.4 million, up 4% from a year earlier, but posted a net loss of $66.6 million, or $3.78 per diluted share, driven by an $88.8 million non-cash goodwill impairment tied to its EMEA segment. Non-GAAP earnings per diluted share fell to $1.71 from $2.13, and management expects a stronger second half with full-year 2025 revenue and earnings in the range of 2024.
Net sales rose 4% to $483.4 million from $463.6 million, with organic sales volumes up 2%.
Net loss of $66.6 million, or $3.78 per diluted share, compared with net income of $34.9 million a year earlier.
Non-GAAP earnings per diluted share were $1.71 versus $2.13; adjusted EBITDA was $75.5 million, down about 10%.
Management expects full-year 2025 revenue and earnings in the range of 2024 and about $20 million of run-rate cost savings by the end of 2026.
Ingersoll Rand reported second quarter 2025 revenue of $1,888 million, up 5%, and raised its full-year 2025 revenue, Adjusted EBITDA and Adjusted EPS guidance. The company also reported a net loss attributable to Ingersoll Rand of $115 million, or $0.29 per share, driven by $265.8 million of non-cash impairments that it says do not affect adjusted earnings. For shareholders, the higher guidance is offset by the reported loss and by Adjusted EPS of $0.80, down from $0.83 a year earlier.
Revenue of $1,888 million, up 5%; orders of $1,940 million, up 8%
Reported net loss attributable to Ingersoll Rand of $115 million, or $0.29 per share, including $265.8 million of goodwill and intangible asset impairments
Adjusted EPS of $0.80 versus $0.83 a year earlier; Adjusted EBITDA of $509 million, up 3%
2025 guidance raised: Adjusted EBITDA of $2,100 million to $2,160 million and Adjusted EPS of $3.34 to $3.46
Camden Property Trust reported second-quarter 2025 EPS of $0.74, up from $0.40 a year earlier, but the filing says about $0.43 per share came from a gain on sale of an operating property. Core FFO per diluted share was $1.70, down from $1.71, and the company raised its 2025 Core FFO guidance to $6.76 to $6.86 from a prior midpoint of $6.78.
Q2 2025 EPS $0.74 vs. $0.40 in Q2 2024; EPS included about $0.43 per share from a gain on sale of an operating property
Q2 2025 Core FFO $1.70 vs. $1.71 a year earlier; Core AFFO $1.43 vs. $1.44
Q2 2025 property revenues $396.5 million vs. $387.2 million in Q2 2024
2025 Core FFO guidance $6.76 to $6.86 (midpoint $6.81, up $0.03); 2025 EPS guidance $2.33 to $2.43
World Kinect reported a GAAP net loss attributable to the company of $339 million, or $6.06 per diluted share, for the second quarter of 2025, compared with net income of $108 million, or $1.81 per share, a year earlier. The loss reflects $367 million of non-cash Land segment intangible asset impairments, including $359 million of goodwill, and an $82 million pre-tax loss on the sale of its U.K. land fuels business, while revenue fell 18% to $9.04 billion and adjusted diluted EPS rose 23% to $0.59.
Revenue was $9.04 billion, down 18% from $10.97 billion a year earlier; gross profit was $232 million, down 5%.
GAAP net loss attributable to World Kinect was $339 million, or $6.06 per diluted share, versus net income of $108 million, or $1.81 per share, in the second quarter of 2024.
Adjusted diluted EPS was $0.59, up 23% from $0.48; the company repurchased $35 million of common stock in the quarter.
The Land segment recorded $367 million of intangible asset impairments, and the U.K. land fuels business sale was completed on April 9, 2025.
DXC Technology reported first quarter fiscal 2026 revenue of $3.16 billion, down 2.4% year over year, and diluted EPS of $0.09, down 35.7%. The company raised its full-year fiscal 2026 non-GAAP diluted EPS guidance to $2.85 to $3.35 from $2.75 to $3.25, while revenue and reported profit declined for the quarter.
Total revenue was $3.16 billion, down 2.4% year over year and down 4.3% on an organic basis
Diluted EPS was $0.09 versus $0.14 a year earlier; non-GAAP diluted EPS was $0.68, down 9.3%
Full-year fiscal 2026 non-GAAP diluted EPS guidance raised to $2.85 to $3.35 from $2.75 to $3.25
Bookings were $2.8 billion, up 14% year over year, and the company repurchased $50 million of shares
Park Hotels & Resorts reported a second-quarter 2025 net loss of $2 million, compared with net income of $67 million a year earlier, as total revenues fell 2.0% to $672 million and Adjusted EBITDA declined to $183 million from $193 million. The company also cut its full-year 2025 outlook for comparable RevPAR and net income, while lowering its net loss range, which matters to shareholders because it signals weaker near-term earnings.
Q2 2025 net loss was $2 million, or $(0.02) per diluted share, versus net income of $67 million, or $0.30 per diluted share, in Q2 2024
Adjusted EBITDA was $183 million, down 5.2%, and diluted Adjusted FFO per share was $0.64, down from $0.65
Full-year 2025 comparable RevPAR outlook was lowered to a range of (2.0)% to 0.0% from (1.0)% to 2.0%, and net loss outlook was set at $(53) million to $(3) million versus $(10) million to $50 million previously
Park sold the Hyatt Centric Fisherman's Wharf for $80 million and will permanently close the Embassy Suites Kansas City Plaza in the third quarter of 2025
Healthcare Realty reported a second-quarter GAAP net loss of $0.45 per share, wider than the $0.39 loss a year earlier, while normalized FFO rose to $0.41 per share from $0.38 and the company raised its 2025 normalized FFO guidance by one cent at the midpoint. The board also cut the common dividend 23% to $0.24 per share, which the company said reduces the FAD payout ratio to approximately 80%. New CEO Peter Scott, who joined April 15, is leading a strategic plan and platform restructuring.
GAAP net loss attributable to common stockholders was $157.9 million, or $(0.45) per share, versus $143.8 million, or $(0.39) per share, in the second quarter of 2024
Normalized FFO was $0.41 per share versus $0.38 a year earlier; 2025 normalized FFO guidance rose to $1.57 to $1.61 from $1.56 to $1.60
Quarterly common dividend of $0.24 per share, payable August 28, 2025, to holders of record on August 14, 2025
Peter Scott joined as President and CEO on April 15, 2025; the board was reduced from 12 to 7 members
Reinsurance Group of America reported second-quarter 2025 net income of $180 million, or $2.70 per diluted share, down from $203 million, or $3.03, a year earlier, while net premiums rose 5.9% to $4.2 billion. CEO Tony Cheng said results were below expectations, mainly due to claims volatility in U.S. Individual Life, and the company also raised its quarterly dividend 4.5% to $0.93 and entered reinsurance agreements covering about $32 billion of Equitable Holdings life insurance liabilities.
Net income available to RGA shareholders was $180 million ($2.70 per diluted share) versus $203 million ($3.03) a year earlier.
Adjusted operating income was $315 million ($4.72 per diluted share) versus $365 million ($5.48).
Quarterly dividend increased 4.5% to $0.93 per share, payable August 26, 2025, to holders of record as of August 12, 2025.
RGA Re ceded a 75% quota share of Equitable's in-force individual life liabilities, about $32 billion, in a transaction the CEO said closed on July 31, 2025.
Bio-Rad reported second-quarter 2025 revenue of $651.6 million, up 2.1% from a year earlier. GAAP net income was $317.8 million, or $11.67 per diluted share, compared with a net loss a year earlier, mainly due to a change in the fair market value of its Sartorius AG investment. Non-GAAP net income fell to $71.0 million, or $2.61 per diluted share, from $88.3 million, or $3.11, and the company raised its non-GAAP operating margin outlook for 2025.
Q2 2025 net sales were $651.6 million, up 2.1% from $638.5 million; currency-neutral sales rose 1.0%.
GAAP net income was $317.8 million, or $11.67 per diluted share, versus a net loss of $(2,165.5) million, or $(76.26) per share, in Q2 2024.
Non-GAAP net income was $71.0 million, or $2.61 per diluted share, versus $88.3 million, or $3.11, a year earlier.
For full-year 2025, non-GAAP operating margin is now expected at approximately 12.0% to 13.0%, up from 10.0% to 12.0%; currency-neutral revenue growth is now expected at approximately 0% to 1.0%, versus a prior range of a 1.0% decline to 1.
Strategy reported second-quarter 2025 net income of $10.02 billion, or $32.60 per diluted share, compared with a net loss of $102.6 million a year earlier. The company said the profit came mainly from a $14.0 billion unrealized gain on its bitcoin holdings, and it issued FY2025 guidance that depends on a year-end bitcoin price of $150,000.
Q2 2025 operating income of $14.03 billion and net income of $10.02 billion, versus a Q2 2024 operating loss of $200.3 million
Total revenues of $114.5 million, up 2.7% year-over-year; gross margin fell to 68.8% from 72.2%
FY2025 guidance: operating income of about $34 billion, net income of about $24 billion, diluted EPS of about $80, assuming a $150,000 year-end bitcoin price
FY2025 BTC $ Gain target raised to $20 billion from $15 billion; BTC Yield target raised to 30% from 25%
Clorox reported fourth-quarter fiscal 2025 net sales up 4% to $2.0 billion and adjusted EPS up 58% to $2.87, helped by incremental ERP-related retailer shipments. For fiscal 2026 it expects net sales down 6% to 10% and adjusted EPS of $5.95 to $6.30, a decline of 18% to 23%, as the ERP shipment benefit reverses.
Q4 net sales rose 4% to $2.0 billion; organic sales rose 8%, with incremental ERP shipments adding about 13 to 14 points
Q4 diluted EPS rose 55% to $2.68 and adjusted EPS rose 58% to $2.87 versus $1.82 a year earlier
FY2026 diluted EPS outlook is $5.60 to $5.95, versus $6.52 in fiscal 2025; adjusted EPS outlook is $5.95 to $6.30 versus $7.72
Net cash provided by operations was $981 million for fiscal 2025, up 41% from $695 million
Illumina reported second-quarter 2025 revenue of $1.06 billion, down 3% from a year earlier on both reported and constant currency bases, while GAAP diluted EPS was $1.49 versus a loss of $12.48 a year earlier. The company raised its full-year 2025 non-GAAP diluted EPS guidance to $4.45 to $4.55 and agreed to acquire SomaLogic from Standard BioTools, a deal expected to close in the first half of 2026.
Q2 2025 revenue of $1.06 billion, down 3% from Q2 2024 on a reported and constant currency basis
GAAP diluted EPS of $1.49 and non-GAAP diluted EPS of $1.19 for Q2 2025; non-GAAP operating margin of 23.8%
FY2025 non-GAAP diluted EPS guidance raised to $4.45 to $4.55, up from $4.20 to $4.30, including about 10 cents from recently passed U.S. R&D tax legislation
Repurchased about 4.5 million shares for $380 million in Q2; about $800 million authorization remaining at quarter end
Roku reported second-quarter 2025 total net revenue of $1.111 billion, up 15% year over year, and net income of $10.5 million, compared with a net loss a year earlier. The company raised its full-year 2025 Platform revenue and Adjusted EBITDA outlook and authorized up to $400 million in share repurchases through December 31, 2026.
Q2 total net revenue was $1.111 billion, up 15% YoY; Platform revenue was $975 million, up 18% YoY
Net income was $10.5 million, or $0.07 per share, versus a net loss of $34.0 million in Q2 2024
Full-year 2025 outlook raised to $4.075 billion Platform revenue and $375 million Adjusted EBITDA; Q2 Adjusted EBITDA was $78 million, up 79%
Board authorized up to $400 million of Class A stock repurchases; Dan Jedda was named Chief Financial Officer and Chief Operating Officer, approved July 28, 2025
Matson reported second-quarter 2025 net income of $94.7 million, or $2.92 per diluted share, down from $113.2 million, or $3.31, a year earlier, on revenue of $830.5 million versus $847.4 million. The company said it is raising its full-year outlook, now expecting Ocean Transportation operating income above its early May guidance but moderately below 2024, while it expects third-quarter consolidated operating income to be meaningfully lower than a year earlier.
Diluted EPS was $2.92 versus $3.31; net income was $94.7 million versus $113.2 million.
Operating income was $113.0 million versus $124.6 million; revenue was $830.5 million versus $847.4 million.
China container volume fell 14.6 percent year-over-year in the second quarter amid tariff-related uncertainty.
For full-year 2025, Ocean Transportation operating income is expected to be higher than early May guidance but moderately lower than 2024; third-quarter consolidated operating income is expected to be meaningfully lower than $242.3 million
Fortune Brands reported second-quarter 2025 net sales of $1.2 billion, down 3% from a year earlier, with GAAP diluted EPS of $0.83, down 22%, and EPS before charges and gains of $1.00, down 14%. The company also issued updated full-year 2025 guidance, including EPS before charges and gains of $3.75 to $3.95 and net sales of down 2% to flat, and said it remains on track to offset anticipated tariff impacts.
Q2 2025 net sales were $1,203.3 million, down 3%; GAAP operating margin was 14.3%, down 180 basis points, and operating margin before charges and gains was 16.5%.
Full-year 2025 guidance: net sales down 2% to flat; EPS before charges and gains $3.75 to $3.95; operating margin before charges and gains 16.0% to 17.0%.
The company repurchased $63 million of shares in Q2 and $238 million year to date; net debt was $2.6 billion as of June 28, 2025.
Corcept reported second quarter 2025 revenue of $194.4 million, up from $163.8 million a year earlier, but net income was $35.1 million versus $35.5 million and diluted earnings per share fell to $0.29 from $0.32. The company modified its 2025 revenue guidance to $850 million to $900 million and said demand outpaced its specialty pharmacy vendor's capacity, which it expects to ease as a second pharmacy comes online.
Q2 2025 revenue $194.4 million vs. $163.8 million in Q2 2024
Net income $35.1 million vs. $35.5 million; diluted EPS $0.29 vs. $0.32
Selling, general and administrative expense $103.9 million vs. $66.9 million a year earlier
2025 revenue guidance modified to $850 million to $900 million; cash and investments $515.0 million at June 30, 2025
Ryan Specialty reported second-quarter 2025 results for the period ended June 30, with total revenue up 23.0% and net income up 5.6%. The company cut its full-year 2025 organic revenue growth guidance to 9.0%-11.0% from 11%-13%, while narrowing its Adjusted EBITDAC margin guidance and declaring a $0.12 quarterly dividend.
Total revenue rose 23.0% year-over-year to $855.2 million; organic revenue growth slowed to 7.1% from 14.2%.
Net income rose 5.6% to $124.7 million; diluted EPS was $0.38 versus $0.37, and adjusted diluted EPS rose 13.8% to $0.66.
Full-year 2025 organic revenue growth guidance was lowered to 9.0%-11.0% from 11%-13.0%; Adjusted EBITDAC margin guidance is now 32.5%-33.0%, from 32.5%-33.5%.
Board declared a $0.12 per share regular quarterly dividend, payable August 26, 2025, to holders of record on August 12, 2025.
Coinbase reported second-quarter 2025 total revenue of $1.5 billion, down 26% from the first quarter, as trading activity fell with lower volatility. Net income was $1.4 billion, but that figure included $1.5 billion in strategic investment gains and a $362 million crypto portfolio gain, while Adjusted Net Income was $33 million and Adjusted EBITDA was $512 million. Shareholders should note the $308 million in operating expenses tied to the data theft incident and the company's Q3 outlook for subscription and services revenue of $665 million to $745 million.
Total revenue was $1.5 billion, down 26% Q/Q; transaction revenue was $764 million, down 39% Q/Q.
Net income was $1.4 billion, versus Adjusted Net Income of $33 million, which excludes $1.5 billion in pre-tax strategic investment gains and a $362 million pre-tax crypto portfolio gain.
Adjusted EBITDA was $512 million, down from $930 million in Q1 2025.
Q3 2025 outlook: subscription and services revenue of $665 million to $745 million; July transaction revenue of approximately $360 million.
Agree Realty reported second-quarter 2025 results and raised its 2025 AFFO per share guidance to $4.29 to $4.32 from $4.27 to $4.30. It also raised its 2025 investment volume guidance to $1.4 billion to $1.6 billion from $1.3 billion to $1.5 billion. Net income per share fell 18.5% to $0.43, while Core FFO and AFFO per share rose, so shareholders get a mixed picture of profit against cash-flow measures.
Q2 2025 net income per share attributable to common stockholders decreased 18.5% to $0.43, from $0.52; net income was $47.3 million, down 10.5%.
Q2 2025 Core FFO per share increased 1.3% to $1.05, and AFFO per share increased 1.7% to $1.06.
2025 AFFO per share guidance raised to $4.29 to $4.32; 2025 investment volume guidance raised to $1.4 billion to $1.6 billion.
Monthly dividend of $0.256 per share declared for June, a 2.4% year-over-year increase; the July dividend is payable August 14, 2025.
Rogers reported second quarter 2025 net sales of $202.8 million, up 6.5% from the prior quarter but down from $214.2 million a year earlier. A net loss of $73.6 million, or $(4.00) per diluted share, reflected $71.8 million of non-cash impairment charges, while adjusted earnings per diluted share were $0.34. The company also announced cost reduction initiatives at its curamik business, with expected charges of $12.0 million to $20.0 million.
Q2 2025 net sales of $202.8 million, up 6.5% sequentially and down from $214.2 million in Q2 2024
GAAP net loss of $73.6 million, or $(4.00) per diluted share, including $71.8 million of non-cash impairment charges and $4.3 million of restructuring expenses
Adjusted EPS of $0.34, up from $0.27 in Q1 2025 and down from $0.69 in Q2 2024
Curamik cost initiatives expected to cut costs by more than $13.0 million annually, with $12.0 million to $20.0 million of expenses; Q3 2025 net sales guidance is $200 million to $215 million
Columbia Sportswear reported second quarter 2025 net sales up 6% to $605.2 million, with a net loss of $10.2 million, or $0.19 per diluted share, narrowed from $0.20 a year earlier. The company gave a limited full year 2025 net sales outlook of $3.33 billion to $3.40 billion and third quarter diluted EPS guidance of $1.00 to $1.20, compared with $1.56 in the prior-year quarter, citing global trade policy uncertainty.
Q2 2025 net sales rose 6% to $605.2 million; operating loss was $23.6 million, versus $23.8 million a year earlier.
Full year 2025 net sales are expected to range from $3.33 billion to $3.40 billion, a decline of 1% to an increase of 1% versus 2024.
Third quarter 2025 diluted EPS is expected at $1.00 to $1.20, compared with $1.56 in the third quarter of 2024.
Board declared a quarterly dividend of $0.30 per share, payable September 4, 2025 to holders of record on August 21, 2025.
AppFolio reported second-quarter 2025 revenue of $236 million, up 19% from a year earlier, and GAAP net income of $36 million, up from $30 million. GAAP operating margin slipped to 17.2% from 18.3%. The company also gave a full-year 2025 revenue outlook of $935 million to $945 million and named Tim Eaton Chief Financial Officer effective July 30, 2025.
Q2 2025 revenue was $235.6 million, up from $197.4 million in Q2 2024
GAAP diluted EPS was $0.99 versus $0.81 a year earlier; GAAP operating margin was 17.2% versus 18.3%
Full-year 2025 revenue is expected at $935 million to $945 million; non-GAAP operating margin at 24.5% to 26.5%
Tim Eaton was appointed CFO effective July 30, 2025, after serving as interim CFO since October 2024
ResMed reported fourth-quarter fiscal 2025 results for the quarter ended June 30, 2025, with revenue up 10% to $1.3 billion and diluted earnings per share up 30% to $2.58. The company also declared a quarterly dividend of $0.60 per share, a 13% increase, payable September 18, 2025 to holders of record on August 14, 2025.
Q4 revenue $1,348.0 million, up 10% (9% constant currency); income from operations up 19% to $454.5 million
Q4 diluted EPS $2.58 vs. $1.98 a year earlier; non-GAAP diluted EPS $2.55 vs. $2.08
Full-year revenue $5.1 billion, up 10%; full-year diluted EPS $9.51 vs. $6.92
Quarterly dividend $0.60 per share; ex-dividend date August 13, 2025
First Solar reported second-quarter 2025 net sales of $1.1 billion, up $0.3 billion from the prior quarter, and diluted earnings of $3.18 per share, up from $1.95 in the first quarter. The company raised its 2025 net sales guidance to $4.9 billion to $5.7 billion and kept the midpoint of its diluted EPS guidance at $15.00, narrowing the range to $13.50 to $16.50. Shareholders get a stronger quarter and a higher sales outlook, though year-over-year quarterly EPS was slightly below the $3.25 reported in the second quarter of 2024.
Q2 2025 net sales $1.1 billion, up $0.3 billion from Q1; net income $341.9 million
Diluted EPS $3.18 versus $1.95 in Q1 2025 and $3.25 in Q2 2024
2025 net sales guidance raised to $4.9 billion to $5.7 billion from $4.5 billion to $5.5 billion
Sold $312 million of Section 45X tax credits for $296 million cash, recognizing a $16 million loss
Casella Waste Systems reported second-quarter 2025 revenue of $465.3 million, up 23.4%, and Adjusted EBITDA of $109.5 million, up 19.5%, but net income fell to $5.2 million. The company raised its full-year revenue guidance and cut its net income guidance to $8 million to $18 million, while reaffirming Adjusted EBITDA guidance of $410 million to $425 million, so shareholders see stronger sales and cash-flow measures alongside lower profit.
Q2 2025 revenue $465.3 million, up $88.2 million from the same period in 2024; net income $5.2 million, down from $7.0 million
Adjusted EBITDA $109.5 million for the quarter, up 19.5%; six acquisitions completed in the first half with over $90 million in annualized revenue
Fiscal 2025 revenue guidance raised to $1.820 billion to $1.840 billion; net income guidance revised to $8 million to $18 million from $10 million to $25 million
Adjusted EBITDA guidance reaffirmed at $410 million to $425 million; the guidance excludes the pending Mountain State Waste acquisition
Perdoceo Education reported second-quarter 2025 revenue of $209.6 million, up 25.7% from $166.7 million a year earlier, and GAAP diluted earnings per share of $0.62 versus $0.57. The board also raised the quarterly dividend 15.4% to $0.15 per share and approved a new $75.0 million share buyback, while the full-year 2025 GAAP earnings per share outlook of $2.29 to $2.36 compares with $2.19 in 2024.
Q2 2025 revenue $209.6 million, up 25.7% from $166.7 million; operating income $51.4 million, up 11.7%.
GAAP diluted EPS $0.62 for the quarter versus $0.57; year to date $1.27 versus $1.16.
Full-year 2025 GAAP EPS outlook $2.29 to $2.36 versus $2.19 in 2024; third-quarter outlook $0.55 to $0.57 versus $0.57.
Quarterly dividend raised to $0.15 per share, payable September 12, 2025; new $75.0 million buyback runs through January 31, 2027.
Kirby reported second-quarter 2025 diluted earnings per share of $1.67, up from $1.43 a year earlier, on revenue of $855.5 million, up from $824.4 million. Management said that if current softness in trade flows and demand persists, 2025 EPS growth will likely be closer to the low end of the prior 15% to 25% range, which matters to shareholders because it signals weaker expected profit growth for the rest of the year.
Q2 2025 net earnings attributable to Kirby were $94.3 million, or $1.67 per diluted share, versus $83.9 million, or $1.43, in Q2 2024
Q2 2025 revenue was $855.5 million, versus $824.4 million; free cash flow was $22.5 million, versus $90.7 million
If current softness persists, 2025 EPS growth will likely be closer to the lower end of the prior 15% to 25% guidance
Total debt rose to $1,117.8 million at June 30, 2025, from $874.9 million at December 31, 2024
Trinity Industries reported second-quarter 2025 results with revenue of $506.2 million and diluted earnings per share from continuing operations of $0.19, both down sharply from the second quarter of 2024. The company kept its full-year 2025 EPS guidance of $1.40 to $1.60, which it said reflects expected higher railcar deliveries in the second half. For shareholders, the quarter shows weaker earnings, while the company has repurchased $39 million of shares so far this year.
Revenue was $506.2 million, compared with $841.4 million a year earlier, mainly due to lower external deliveries in the Rail Products Group.
Diluted EPS from continuing operations was $0.19, compared with $0.67 a year earlier; net income attributable to Trinity Industries was $14.1 million, compared with $54.4 million.
Full-year 2025 EPS guidance of $1.40 to $1.60 was maintained.
Railcar deliveries were 1,815 in the quarter, compared with 4,755 a year earlier; orders were 2,310, and the book-to-bill ratio was 1.3x.
AGCO reported second-quarter 2025 net sales of $2.6 billion, down 18.8% from a year earlier, and reported net income of $4.22 per share versus a loss of $4.92 per share in the prior-year quarter. Adjusted earnings per share fell to $1.35 from $2.53, and the company raised its full-year net sales and earnings per share outlook, with reported quarterly results helped by a $205.5 million income tax benefit.
Q2 2025 net sales were $2.6 billion, down 18.8% year over year and down 22.3% excluding currency translation.
Reported EPS was $4.22 versus $(4.92) a year earlier; adjusted EPS was $1.35 versus $2.53.
Full-year 2025 net sales are now expected at approximately $9.8 billion, with EPS now targeted between $4.75 and $5.00.
On July 9, 2025, the Board authorized a new share repurchase program of up to $1.0 billion of common stock.
Millrose Properties reported second-quarter 2025 net income attributable to common shareholders of $112.8 million, or $0.68 per share, driven by $149.0 million in option fees and other related income. The company raised its year-end AFFO quarterly run rate guidance to $0.70 to $0.73 per share, citing higher transaction funding outside the Lennar Master Program Agreement.
Q2 2025 net income attributable to common shareholders was $112.8 million, or $0.68 per share, versus a net loss of $59.8 million in the prior-year period.
Adjusted Funds From Operations (AFFO) was $115.0 million, or $0.69 per share.
Year-end AFFO quarterly run rate guidance raised to $0.70 to $0.73 per share.
Net cash proceeds from homesite sales were $797 million, including $768 million from Lennar; the company also reported a $1 billion delayed draw term loan closed during the quarter.
InterDigital reported second-quarter 2025 revenue of $300.6 million, up 34% year over year, driven by the conclusion of the Samsung arbitration and a new license agreement with HP. The company raised its full-year 2025 revenue outlook to $790 million to $850 million from $660 million to $760 million, which matters to shareholders because it signals higher expected licensing revenue for the year.
Q2 2025 revenue of $300.6 million, up 34% year over year, and net income of $180.6 million, up 65%
Diluted EPS of $5.35 for the quarter, up 36% from $3.93 a year earlier
Full-year 2025 revenue outlook raised to $790 million to $850 million from $660 million to $760 million
Third-quarter 2025 revenue outlook of $136 million to $140 million, covering existing licenses only
National Fuel Gas reported third-quarter fiscal 2025 GAAP earnings of $149.8 million, or $1.64 per share, compared with a net loss of $54.2 million, or $0.59 per share, a year earlier. The company revised its fiscal 2025 adjusted EPS guidance to $6.80 to $6.95 and issued preliminary fiscal 2026 guidance of $8.00 to $8.50 per share at a $4.00 NYMEX gas price, which it says would be a 20% increase from fiscal 2025. It also raised its dividend 4% to an annual rate of $2.14 per share and paused share repurchases during the quarter.
Q3 adjusted EPS of $1.64 rose 66% from $0.99; Seneca produced a company-record 112 Bcf, up 16%
Fiscal 2025 adjusted EPS guidance revised to $6.80 to $6.95 per share
Preliminary fiscal 2026 adjusted EPS: $6.35 to $6.85 at $3.00 NYMEX, $8.00 to $8.50 at $4.00, $9.75 to $10.25 at $5.00
Dividend increased 4% to an annual rate of $2.14 per share; repurchases paused during the quarter
BorgWarner reported second quarter 2025 net sales of $3,638 million, up about 1% from a year earlier, and U.S. GAAP net earnings of $1.03 per diluted share, down from $1.39. Adjusted earnings were $1.21 per diluted share, up about 2%, and the company raised its full-year 2025 adjusted earnings per share guidance to $4.45 to $4.65 from $4.00 to $4.45. The board also raised the quarterly dividend 55% to $0.17 per share and increased the share repurchase authorization to $1 billion.
Q2 2025 U.S. GAAP net earnings were $224 million, or $1.03 per diluted share, compared with $315 million, or $1.39, in Q2 2024.
Full-year 2025 net sales guidance raised to $14.0 billion to $14.4 billion; GAAP net earnings guidance set at $3.80 to $3.97 per diluted share.
Quarterly cash dividend increased 55% to $0.17 per share, payable September 15, 2025, to holders of record on September 2, 2025.
Share repurchase authorization increased to $1 billion; the company bought about $108 million of its shares in the second quarter.
Alnylam reported second quarter 2025 total net product revenues of $672 million, up 64% from a year earlier, and raised its full-year 2025 total net product revenue guidance to $2,650 million to $2,800 million from $2,050 million to $2,250 million. The company also posted a GAAP loss from operations of $16.2 million, compared with income of $48.6 million a year earlier, and a GAAP net loss of $0.51 per share versus $0.13 in the prior-year quarter.
Q2 2025 total revenues were $773.7 million, up 17% from $659.8 million in Q2 2024
AMVUTTRA net product revenues were $492 million, up 114%; total TTR net product revenues were $544 million, up 77%
GAAP loss from operations was $16.2 million, versus income of $48.6 million; non-GAAP income from operations fell 31% to $95.5 million
Cost of goods sold rose to $142.0 million from $67.3 million, and GAAP SG&A expenses rose 30% to $323.3 million
Upbound Group reported second-quarter 2025 revenue of $1.16 billion, up 7.5% from a year earlier, and non-GAAP diluted EPS of $1.12, up from $1.04. GAAP diluted EPS fell to $0.26 from $0.61 because of $65.5 million in pre-tax special items, including legal matters. The company raised the midpoint of its full-year 2025 non-GAAP EPS guidance to $4.05 to $4.40 from $4.00 to $4.40.
Q2 2025 consolidated revenue was $1,157.5 million, up 7.5% year over year, helped by the Brigit acquisition.
GAAP net earnings were $15.5 million, down from $33.9 million; GAAP operating profit was $50.7 million, down from $80.7 million.
FY 2025 non-GAAP diluted EPS guidance midpoint raised; Adjusted EBITDA guidance narrowed to $515 million to $535 million from $510 million to $540 million.
Q3 2025 guidance: revenue of $1.05 billion to $1.15 billion and non-GAAP diluted EPS of $0.95 to $1.05.
Peabody reported a second-quarter net loss attributable to common stockholders of $27.6 million, or $0.23 per diluted share, compared with net income of $199.4 million, or $1.42 per share, a year earlier. Revenue fell to $890.1 million from $1,042.0 million, and Adjusted EBITDA fell to $93.3 million from $309.7 million, while the company raised some full-year volume targets and lowered cost targets for three segments. The company also said a Material Adverse Change has occurred under its purchase agreements for the Anglo American Moranbah North acquisition and plans a further update on August 19, 2025.
Q2 2025 net loss attributable to common stockholders of $27.6 million, or $0.23 per diluted share, versus $199.4 million, or $1.42 per share, in Q2 2024
Q2 revenue of $890.1 million versus $1,042.0 million a year earlier; Adjusted EBITDA of $93.3 million versus $309.7 million
Full-year 2025 PRB volume guidance raised by 5 million tons; Seaborne Metallurgical full-year cost guidance lowered by $7 per ton to approximately $118 per ton
Quarterly dividend of $0.075 per share payable September 3, 2025 to holders of record August 14, 2025
ATI reported second quarter 2025 sales of $1.14 billion, up 4% year over year, with net income attributable to ATI of $100.7 million, or $0.70 per diluted share, compared with $0.58 a year earlier. The company raised the mid-point of its full-year 2025 adjusted earnings and cash flow guidance and repurchased $250 million of stock in the quarter, bringing 2025 buybacks to $320 million.
Q2 2025 sales of $1.14 billion, up 4% year over year, with aerospace and defense sales of $761.8 million, or 67% of sales
Net income attributable to ATI of $100.7 million, up 23% year over year; adjusted EPS of $0.74 versus $0.60 a year earlier
Full-year 2025 adjusted EBITDA guidance of $810 million to $840 million and adjusted EPS guidance of $2.90 to $3.07; Q3 adjusted EBITDA guidance of $200 million to $210 million
Repurchased $250 million of common stock in Q2; $270 million of buyback authorization remains as of June 29, 2025
Laureate Education reported second-quarter 2025 revenue of $524.2 million, up 5% on a reported basis, and operating income of $193.3 million, up from $166.6 million. Net income fell to $97.4 million from $128.4 million, mainly due to a $25.6 million foreign currency exchange loss, and diluted earnings per share were $0.65 versus $0.83. The company raised its full-year 2025 revenue and Adjusted EBITDA guidance, citing more favorable foreign currency rates.
Q2 2025 revenue $524.2 million, up 5% reported and up 10% organic constant currency
Q2 net income $97.4 million vs. $128.4 million a year earlier; diluted EPS $0.65 vs. $0.83
2025 revenue guidance raised by about $55 million to $1,615 million–$1,630 million
2025 Adjusted EBITDA guidance raised by about $16 million to $489 million–$496 million
Terex reported second quarter 2025 net sales of $1.5 billion, up 7.6% from a year earlier, while GAAP diluted EPS fell to $1.09 from $2.08 and adjusted EPS fell to $1.49 from $2.16. The board authorized a new $150 million share repurchase program and the company kept its full-year adjusted EPS outlook of $4.70 to $5.10.
Q2 2025 operating margin was 8.7% (11.0% adjusted), versus 14.0% a year earlier
Aerials net sales fell 17.1% to $607 million; Materials Processing fell 9.0% to $454 million; Environmental Solutions rose 12.9% on a pro forma basis to $430 million
Free cash flow was $78 million, up from $43 million; liquidity was $1.2 billion as of June 30, 2025
Full-year 2025 outlook: net sales $5.3 billion to $5.5 billion, adjusted EPS $4.70 to $5.10, assuming tariffs remain at current rates
Howmet Aerospace reported second quarter 2025 revenue of $2.05 billion, up 9% year over year, and net income of $407 million, or $1.00 per diluted share, versus $266 million, or $0.65, a year earlier. The company raised its full-year 2025 guidance on all metrics and increased its quarterly dividend by 20%, which benefits shareholders.
Net income was $407 million, or $1.00 per diluted share, versus $266 million, or $0.65, in second quarter 2024, including about $36 million in net benefits from special items.
Adjusted EPS excluding special items was $0.91, up 36% year over year; adjusted EBITDA excluding special items was $589 million, up 22%.
Repurchased $175 million of stock in second quarter 2025 and $100 million in July 2025; quarterly dividend raised 20% to $0.12 per share, payable August 25, 2025.
Teleflex reported second-quarter 2025 GAAP revenue of $780.9 million, up 4.2% from a year earlier, and GAAP diluted EPS from continuing operations of $2.77, compared with $1.69. The company raised its full-year 2025 guidance, which it says includes the BIOTRONIK Vascular Intervention business acquired at the start of the third quarter. Management said underlying adjusted constant currency revenue guidance, excluding the acquisition, is unchanged.
Adjusted diluted EPS from continuing operations was $3.73, compared with $3.42 in the prior year period; adjusted constant currency revenue growth was 1.0%.
2025 GAAP diluted EPS from continuing operations guidance was raised to $6.73 to $7.13, from $6.51 to $6.91.
2025 adjusted diluted EPS guidance was raised to $13.90 to $14.30, from $13.20 to $13.60.
The acquired BIOTRONIK business is expected to generate $204 million of revenue in the second half of 2025.
Quanta Services reported second-quarter 2025 revenue of $6.77 billion, up from $5.59 billion a year earlier, and GAAP diluted EPS of $1.52, up from $1.26. The company raised its full-year 2025 outlook and said the increase reflects its second-quarter results and the July 25, 2025 acquisition of Dynamic Systems for up to $1.566 billion.
Q2 2025 revenue was $6.77 billion versus $5.59 billion in Q2 2024; net income attributable to common stock was $229.3 million.
Q2 GAAP diluted EPS was $1.52 versus $1.26; adjusted diluted EPS was $2.48 versus $1.90.
Full-year 2025 revenue outlook is now $27.4 billion to $27.9 billion, and GAAP diluted EPS is now $6.47 to $7.07.
Dynamic Systems was acquired on July 25, 2025 for up to $1.566 billion, including a $216 million earnout; $202.5 million of base consideration was paid in Quanta common stock.
CVS Health reported second-quarter 2025 revenue of $98.9 billion, up 8.4%, but GAAP diluted EPS fell to $0.80 from $1.41 after $833 million in litigation charges. The company raised its full-year adjusted EPS guidance to $6.30 to $6.40 while cutting its GAAP EPS guidance to $3.84 to $3.94, so shareholders face a mixed picture of stronger underlying performance and lower reported profit.
Q2 total revenues were $98.9 billion, up from $91.2 billion a year earlier; adjusted EPS was $1.81 versus $1.83
GAAP diluted EPS guidance was revised to $3.84 to $3.94 from $4.23 to $4.43
Adjusted EPS guidance was raised to $6.30 to $6.40 from $6.00 to $6.20
Cash flow from operations guidance was raised to at least $7.5 billion from about $7.0 billion
Integra LifeSciences reported second-quarter 2025 revenue of $415.6 million, down 0.6% from a year earlier, and adjusted earnings of $0.45 per diluted share, versus $0.63 a year earlier. A $511 million goodwill impairment charge drove a GAAP net loss of $484.1 million, or $(6.31) per diluted share. The company updated its full-year revenue guidance to $1.655 billion to $1.680 billion and reaffirmed adjusted EPS guidance of $2.19 to $2.29.
Revenue $415.6 million, down 0.6% reported and 1.4% organic versus Q2 2024
GAAP net loss $484.1 million, or $(6.31) per diluted share, versus $(12.4) million a year earlier, mainly from the $511 million goodwill impairment
Adjusted EPS $0.45 versus $0.63; Q3 2025 adjusted EPS expected at $0.40 to $0.45
Net debt $1.59 billion at June 30, 2025; total leverage ratio 4.5x
Euronet reported second-quarter 2025 results for the period ended June 30, 2025. Revenue rose 9% to $1,074.3 million and operating income rose 18% to $158.6 million, while diluted EPS was $2.27 versus $1.73 a year earlier and adjusted EPS rose 14% to $2.56. The company expects 2025 adjusted EPS to grow 12% to 16%, and the release references a merger agreement with CoreCard dated July 30, 2025.
Revenue of $1,074.3 million, up 9% from $986.2 million (6% on a constant currency basis)
Operating income of $158.6 million, up 18% from $134.3 million
Diluted EPS of $2.27 versus $1.73; adjusted EPS of $2.56 versus $2.25
2025 outlook calls for adjusted EPS growth of 12% to 16%; Agreement and Plan of Merger with CoreCard dated July 30, 2025
WESCO International reported second-quarter 2025 net sales of $5.90 billion, up 7.7% from a year earlier, and raised its full-year 2025 organic sales growth outlook while keeping its EPS midpoint unchanged. GAAP diluted EPS fell 10.5% to $3.83, while adjusted diluted EPS rose 5.6% to $3.39 and adjusted EBITDA declined 1.5%, mainly due to lower gross margin from large project wins and higher SG&A expenses.
Q2 net sales $5,899.6 million, up 7.7%; organic sales up 7.2%
GAAP diluted EPS $3.83 vs. $4.28; adjusted diluted EPS $3.39 vs. $3.21
Adjusted EBITDA $394.2 million, down 1.5%; adjusted EBITDA margin 6.7% vs. 7.3%
Full-year 2025 organic sales growth outlook raised; EPS midpoint maintained
Pilgrim's Pride reported second-quarter 2025 net sales of $4.8 billion, up 4.3% from a year earlier, and GAAP EPS of $1.49 versus $1.37. The board also declared a $2.10 per share dividend, which the company says totals about $500 million, payable to holders of record on August 20, 2025.
Net sales were $4,757.4 million, up 4.3% from $4,559.3 million in the second quarter of 2024.
GAAP EPS was $1.49, up from $1.37; operating income was $512.3 million, up 16.2%.
The board declared a $2.10 per share dividend, about $500 million in total, to stockholders of record at the close of business on August 20, 2025.
Management will hold a conference call on July 31, 2025 at 7 a.m. MT (9 a.m. ET).
Cactus reported second-quarter 2025 revenue of $273.6 million and net income of $49.0 million, both lower than a year earlier, with diluted earnings per Class A share of $0.59 versus $0.75. The company expects third-quarter revenue to be down modestly in both segments as U.S. land activity declines, and it agreed to acquire a 65% majority interest in Baker Hughes' Surface Pressure Control business.
Q2 2025 revenue was $273.6 million, versus $290.4 million in Q2 2024; net income was $49.0 million, versus $63.1 million
Adjusted EBITDA was $86.7 million with a 31.7% margin, versus $103.6 million and 35.7% a year earlier
Management expects third-quarter 2025 revenues to be down modestly in both the Pressure Control and Spoolable Technologies segments
Quarterly Class A dividend raised 8% to $0.14 per share, payable September 18, 2025 to holders of record on August 29, 2025
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.